An anti-IFNAR antibody also reduced sepsis symptoms and was functional even when injected after CLP induction, thus reinforcing the potential of IFN-β signaling inactivation as a therapeutic approach for sepsis (76). This evidence concerns the gene IFNAR1 and Sepsis.